Full Text
The Full Text of this article is available as a PDF (168.6 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cohen J. A., Cutter G. R., Fischer J. S., Goodman A. D., Heidenreich F. R., Jak A. J., Kniker J. E., Kooijmans M. F., Lull J. M., Sandrock A. W. Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial. Arch Neurol. 2001 Jun;58(6):961–967. doi: 10.1001/archneur.58.6.961. [DOI] [PubMed] [Google Scholar]
- Hobart J. C., Riazi A., Lamping D. L., Fitzpatrick R., Thompson A. J. Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12). Neurology. 2003 Jan 14;60(1):31–36. doi: 10.1212/wnl.60.1.31. [DOI] [PubMed] [Google Scholar]
- Massof Robert W. The measurement of vision disability. Optom Vis Sci. 2002 Aug;79(8):516–552. doi: 10.1097/00006324-200208000-00015. [DOI] [PubMed] [Google Scholar]
- Wright B. D., Linacre J. M. Observations are always ordinal; measurements, however, must be interval. Arch Phys Med Rehabil. 1989 Nov;70(12):857–860. [PubMed] [Google Scholar]